Coagulation, Bradykinin, Polyphosphates, and Angioedema
Type
article
Field-Weighted Citation Impact
4.88
Funders
BioCryst
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article
Long-term safety and efficacy of once-daily berotralstat in patients with hereditary angioedema
Jonny Peter, Avner Reshef, Douglas Johnston, Miloš Jeseňák et al.
Citations
3 citations
Journal
Annals of Allergy Asthma & Immunology
Topics
Coagulation, Bradykinin, Polyphosphates, and Angioedema
Field-Weighted Citation Impact (FWCI)
4.88
article
Long-term safety and efficacy of once-daily berotralstat in patients with hereditary angioedema
Jonny Peter, Avner Reshef, Douglas Johnston, Miloš Jeseňák, Aleena Banerji, Heather A. Iocca, Sorena Kiani‐Alikhan, David Hagin, Tamar Kinaciyan, Marcin Stobiecki, Lindsey Noble, Henriette Farkas, Emel Aygören‐Pürsün, Aharon Kessel, Adrian Wu, John Anderson, Michael Manning, Dianne Tomita
article en
3 citations
Abstract
No abstract available for this paper.
Publication Tag
Annals of Allergy Asthma & ImmunologyVol. 135(3)
Institutions
Goethe University Frankfurt (DE), National Health Service (GB), Jagiellonian University (PL), Tel Aviv Sourasky Medical Center (IL), The Royal Free Hospital (GB), Barzilai Medical Center (IL), Bnai Zion Medical Center (IL), BioCryst Pharmaceuticals (United States) (US), University Hospital Frankfurt (DE), University College London (GB), Medical University of Vienna (AT)
Funders
BioCryst
Sustainable Development Goals
Zero hunger
OpenAlex Percentile
Openalex Percentile: Top 5%
Topics
Coagulation, Bradykinin, Polyphosphates, and Angioedema